NCT04399954 - Evaluation of Ketoflo | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 24, 2020

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions

Epilepsy IntractableGlucose Transporter Type 1 Deficiency SyndromeKetogenic Dieting

Interventions

DIETARY_SUPPLEMENT

Ketoflo

Ketoflo is a ready to use liquid feed for the dietary management of epilepsy and other conditions that may require a ketogenic diet. It has a 4:1 ratio of fat to carbohydrate and protein and can be administered enterally via a tube feeding or oral consumption.

Trial Locations (5)

AB25 2ZG

Royal Aberdeen Children's Hospital, Aberdeen

B15 2SY

Barberry, Birmingham

BS2 8BJ

Bristol Royal Hospital for Children, Bristol

LS1 3EX

Leeds Children's Hospital, Leeds

WC1N 3JH

Great Ormond Street Hospital for Children, London

All Listed Sponsors

lead

Vitaflo International, Ltd

INDUSTRY